970324498	970324498	CD	B-NP	O
|	|	NNP	I-NP	O
VH	VH	NNP	I-NP	O
|	|	VBD	B-VP	O
86541725	86541725	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
589819	589819	CD	B-NP	O
|	|	CC	I-NP	O
11/27/1998	11/27/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/23/1998	10/23/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/15/1998	2/15/1998	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
COMMUNITY	COMMUNITY	NNP	B-NP	O
ACQUIRED	ACQUIRED	NNP	I-NP	O
PNEUMONIA	PNEUMONIA	NNP	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COMMUNITY	COMMUNITY	NNP	I-NP	O
ACQUIRED	ACQUIRED	NNP	I-NP	O
PNEUMONIA	PNEUMONIA	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
MYOCARDIAL	MYOCARDIAL	JJ	B-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
NON-INSULIN	NON-INSULIN	NN	I-NP	B-protein
DEPENDENT	DEPENDENT	NN	I-NP	O
DIABETES	DIABETES	NNS	I-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
RECENT	RECENT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
OF	OF	IN	B-PP	O
SLEEP	SLEEP	NN	B-NP	O
APNEA	APNEA	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
male	male	JJ	I-NP	O
whose	whose	WP$	I-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
without	without	IN	B-PP	O
residual	residual	JJ	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
non-insulin	non-insulin	JJ	B-NP	O
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
occasionally	occasionally	RB	B-ADVP	O
of	of	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
temperatures	temperature	NNS	I-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
healthcare	healthcare	NN	I-NP	O
provider	provider	NN	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
given	give	VBN	B-NP	O
Erythromycin	Erythromycin	NN	I-NP	O
and	and	CC	I-NP	O
Ciprofloxacin	Ciprofloxacin	NN	I-NP	O
without	without	IN	B-PP	O
improvement	improvement	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
went	go	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
cough	cough	NN	B-NP	O
syrup	syrup	NN	I-NP	O
with	with	IN	B-PP	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
and	and	CC	B-PP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
and	and	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
degrees	degree	NNS	I-NP	O
with	with	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
between	between	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
outpatient	outpatient	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
100.1	100.1	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/80	130/80	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
HEENT	HEENT	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lung	lung	NN	I-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
rhonchorous	rhonchorous	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
throughout	throughout	IN	B-ADVP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
bases	base	NNS	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
and	and	CC	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
neurological	neurological	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
non-focal	non-focal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
chem-7	chem-7	NN	I-NP	B-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
CBC	CBC	NN	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7.3	7.3	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
33.5	33.5	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
130	130	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
focal	focal	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
sleep	sleep	VB	B-VP	O
apnea	apnea	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
failed	fail	VBN	I-VP	O
outpatient	outpatient	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Cefuroxime	Cefuroxime	NN	I-NP	O
and	and	CC	I-NP	O
Azithromycin	Azithromycin	NN	I-NP	O
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
bacterial	bacterial	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
and	and	CC	O	O
atypical	atypical	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	O	O
sputums	sputum	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-NP	O
no	no	DT	I-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
ever	ever	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
two	two	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
of	of	IN	B-PP	O
roughly	roughly	RB	B-NP	O
86	86	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
six	six	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
lung	lung	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
marked	marked	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
and	and	CC	I-NP	O
expiratory	expiratory	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
air	air	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
examination	examination	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
event	event	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
bronchospasm	bronchospasm	NN	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
airway	airway	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
Albuterol	Albuterol	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
and	and	CC	O	O
intravenous	intravenous	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
his	his	PRP$	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
gradually	gradually	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
six	six	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
airway	airway	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
perhaps	perhaps	RB	B-VP	O
worsening	worsen	VBG	I-VP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
Legionella	Legionella	NNP	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Azithromycin	Azithromycin	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
causing	cause	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	O
problems	problem	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
raised	raise	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
precipitant	precipitant	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
70	70	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
become	become	VB	I-VP	O
obviously	obviously	RB	B-ADJP	O
fluid	fluid	JJ	I-ADJP	O
overloaded	overload	VBN	B-VP	O
.	.	.	O	O

Nonetheless	Nonetheless	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
work-up	work-up	NN	I-NP	O
which	which	WDT	B-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
apical	apical	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
inferoseptal	inferoseptal	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
marked	marked	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
unlikely	unlikely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
flash	flash	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
treated	treat	VBN	I-VP	O
solely	solely	RB	B-ADVP	O
for	for	IN	B-PP	O
severe	severe	JJ	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
bronchospastic	bronchospastic	JJ	I-NP	O
component	component	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Cefuroxime	Cefuroxime	NN	B-NP	O
and	and	CC	I-NP	O
Azithromycin	Azithromycin	NN	I-NP	O
with	with	IN	B-PP	O
gradual	gradual	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Prednisone	Prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
underwent	undergo	VBD	B-VP	O
marked	marked	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
bronchospasm	bronchospasm	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Biaxin	Biaxin	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
course	course	NN	I-NP	O
for	for	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Albuterol	Albuterol	NNP	I-NP	O
inhaler	inhaler	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Enteric	Enteric	JJ	I-NP	O
coated	coat	VBN	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Glyburide	Glyburide	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Lopressor	Lopressor	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Prednisone	Prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Timoptic	Timoptic	JJ	I-NP	O
one	one	CD	I-NP	O
drop	drop	NN	I-NP	O
o.u.	o.u.	NN	I-NP	O
q.	q.	NNP	I-NP	O
PM	PM	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardura	Cardura	NNP	I-NP	O
one	one	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
asked	ask	VBD	I-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
laboratory	laboratory	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
which	which	WDT	B-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
through	through	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
microcytic	microcytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
iron	iron	NN	B-NP	O
studies	study	NNS	I-NP	O
sent	send	VBN	B-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
iron	iron	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
TIBC	TIBC	NN	I-NP	B-protein
of	of	IN	B-PP	O
241	241	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
DYLAN	DYLAN	NNP	B-NP	O
VIRTS	VIRTS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
YR82	YR82	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KING	KING	NNP	B-NP	O
Q.	Q.	NNP	I-NP	O
LANTHIER	LANTHIER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OJ88	OJ88	NNP	I-NP	O
JU077/1969	JU077/1969	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
58572	58572	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

QPCKEEOM1	QPCKEEOM1	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/3/98	9/3/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/25/98	5/25/98	CD	B-NP	O

